Status:
COMPLETED
Effects of the Cornelian Cherry Supplementation on the Selected Physiological Parameters in Marathon Runners
Lead Sponsor:
Wroclaw Medical University
Collaborating Sponsors:
Wrocław University of Environmental and Life Sciences
Conditions:
Healthy
Eligibility:
MALE
45-75 years
Phase:
NA
Brief Summary
Growing body of evidence indicates favorable effects of Cornus mas (Cornelian cherry) supplements on cardiometabolic risk, including the improvement of HDL and glycemic indices, in line with vascular ...
Eligibility Criteria
Inclusion
- age above 45 years
Exclusion
- chronic disease of the nervous, cardiovascular or respiratory system
- disease of the digestive system, including history of the intestinal surgery, inflammatory bowel disease, celiac disease, lactose intolerance and other malabsorption disorders
- blood pressure-lowering treatment within the past year
- tobacco smoking within the past year
- antibiotic/probiotic treatment and laxative/prokinetic usage in three months preceding the anticipated enrollment
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 21 2022
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT07194720
Start Date
September 15 2021
End Date
April 21 2022
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wroclaw Medical University
Wroclaw, Lower Silesian Voivodeship, Poland, 50-376